SOVREMENNAYA PEDIATRIYA.2016.5(77):34-39; doi10.15574/SP.2016.77.34 

Complex therapy of acute respiratory infections in children 

Beketova G. V., Soldatova O. V., Gan R. Z.

Shupyk National Medical Academy of Postgraduate Education, Kiev, Ukraine 

In the article the features of the etiology, pathogenesis and clinical manifestations of acute respiratory infections (ARI) in children are presented. The authors have substantiated indications for symptomatic treatment, taking into account the basic pathogenesis of ARI. The questions of the possibility of use of complex preparations for the treatment of acute respiratory infections in children, which are allowed providing multisimptomatic effects such as analgesic, antipyretic, anti-inflammatory, antiallergic and antitussive are underlined. One of such preparation is «Milistan multisimptomatic». The use of complex preparation «Milistan multisimptomatic» allows to effect on all the main links of the ARI pathogenesis, quickly and effectively removes the clinical symptoms and improves quality of life for patients.

Key words: acute respiratory infections, symptomatic treatment, combined preparations, children.

REFERENCES

1. Volkov IK. 2013. Kashel u detey. Prichinyi i lechenie. Russkiy med. zhurn. 21; 25: 1218—1221.

2. Gorenkov RV. 2011. Aktualnyie voprosyi diagnostiki i lecheniya ostryih respiratornyih zabolevaniy v praktike vracha. Meditsina nevIdkladnih stanIv. 3(34).

3. Zharkova NE. 2007. Simptomaticheskoe lechenie ORVI: buduschee za kombinirovannyimi preparatami. Russkiy med zhurn. 15; 22: 1636—1639.

4. Zaytsev AA. 2009. Napravleniya farmakoterapii i profilaktiki ostryih respiratornyih virusnyih infektsiy. Russkiy med zhurn. 14; 27: 1968—1973.

5. Infektsii respiratornogo trakta u detey rannego vozrasta. Pod red prof GA Samsyiginoy. Moskva, Miklosh. 2006: 111—136.

6. Ketova GG. 2008. Osobennosti ispolzovaniya zharoponizhayuschih preparatov u detey. RMZh. 18: 1170—1172.

7. Kramarev SA. 2012. Lechenie lihoradki u detey. Zdorove rebenka. 8(43).

8. Lipatova MK. 2006. Sotsialnaya znachimost ORVI i aktualnost simptomaticheskogo lecheniya. Russkiy med zhurn. 14; 24: 1569—1574.

9. Maydannik VG. 2005. Kashel u detey: prichinyi, mehanizmyi, diagnostika i lechenie. Sovremennaya pediatriya. 3: 23—27.

10. Markova TP. 2010. Profilaktika i lechenie respiratornyih infektsiy. Russkiy med zhurn. 18; 2: 77—82.

11. Zaplatnikov AL, Gluhareva NS, Koroid NV, Mingalimova GA. 2011. Ostryie respiratornyie infektsii u detey: printsipyi ratsionalnoy terapii. Consilium Medicum. Vrachebnyiy konsilium. 13; 3: 46—51.

12. Paramonova NS, Sorokopyit ZV. 2011. Kashel u detey: sovremennyie podhodyi k diagnostike i lecheniyu. Zhurnal Grodnenskogo gos med un-ta. 1(33): 78—81.

13. Pchelintsev MV. 2009. Novyie kliniko-farmakologicheskie aspektyi simptomaticheskoy terapii ORVI i grippa. Russkiy med zhurn. 17; 14: 924—928.

14. Vetrov VP, Dlin VV, Osmanov VV et al. 2006. Ratsionalnoe ispolzovanie antipiretikov v detskom vozdaste. Posobie dlya vrachey. Moskva: 26.

15. Rovkina EI. 2012. Simptomaticheskaya terapiya kak vazhneyshee zveno terapii kashlya. Lechaschiy vrach. 4.

16. Romantsov MG, Kiselev OI, Sologub TV. 2011. Etiopatogeneticheskaya farmakoterapiya ORVI i grippa. Lechaschiy vrach. 2.

17. Stremouhov AA, Mischenko EB. 2003. Lechenie rinita pri ostryih respiratornyih virusnyih infektsiyah antigistaminnyimi preparatami pervogo pokoleniya. Lechaschiy vrach. 2: 77.

18. Chernyisheva OE, Krivuschev BI. 2011. Sindrom kashlya u detey i ego patogeneticheskoe lechenie. Zdorove rebenka. 7.

19. Chernyishova OE, Krivuschev BI. 2009. Preparatyi kombinirovannogo deystviya v lechenii ORVI u detey. Zdorove rebenka. 1(16).

20. Yulish EI, Talalaenko AA. 2014. Lihoradka u detey: taktika pediatra. Zdorove rebenka. 1(52).

21. Berger G, Kattan A, Bernheim J et al. 2000. Acute Sinusitis: A Histopathological and Immunohistochemical Study. Laryngoscope. 110: 2089—94. http://dx.doi.org/10.1097/00005537-200012000-00022; PMid:11129027

22. Ford LB, Matz J, Hankinson T et al. 2015. Allergy and Asthma Proceedings. The Asthma and Allergy Center. Bellevue, Nebraska, USA.

23. American Academy of Pediatrics. Health issues. Medications used to treat fever. URL: http://www.healthychildren.org, Accessed February 8, 2011.

24. Sutter AI, Lemiengre M, Campbel H, Mackinnon HF. 2003. Antihistamines for the common cold. Cohrane Detabase Syst Rev. 3: CD001267. http://dx.doi.org/10.1002/14651858.cd001267

25. Brodlie M, Graham C, McKean MC. 2012, Mar 6. Childhood cough. BMJ. 344: e1177. doi: 10.1136/bmj.e1177. http://dx.doi.org/10.1136/bmj.e1177

26. Chang AB, Peake J, McElrea MS. 2008. Anti-Histamines for prolonged non-specific cough in chikdren. The Cochrane Library.

27. Paul IM, Yoder KE, Crowell KR et al. 2004. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics. 114(1): e85-90. http://dx.doi.org/10.1542/peds.114.1.e85.

28. Gillard M, Christophe B, Wels B et al. 2003. H1 antagonists: receptor affinity versus selectivity. Inflamm Res. 52; Suppl 1: 49—50. http://dx.doi.org/10.1007/s000110300050

29. Muether PS, Gwaltney JMJr. 2001, Nov 1. Variant Еffect of first- and second-generation antihistamines as clues to their mechanism of action on the sneeze reflex in the commoncold. Clin Infect Dis. 33(9): 1483—1488. http://dx.doi.org/10.1086/322518; PMid:11588693

30. De Sutter AI, van Driel ML, Kumar AA et al. 2012, Feb 15. Oral antihistamine-decongestant-analgesic combinations for the common cold. Cochrane Database Syst Rev. 2: CD004976. http://dx.doi.org/10.1002/14651858.CD004976.pub3.

31. Uguz A, Sanlioglu S, Yuzbey S et al. 2010. The effect of cetirizine on IFN-γ and IL-10 production in children with allergic rhinitis. The Turk J Pediatr. 7(64): 134—138.

32. De Esch IJ, Thurmond RL, Jongejan A, Leurs R. 2005. The histamine H4 receptor as a new therapeutic target for inflammation. Trends Pharmacol Sci. 26(9): 462—469. PMid:16054239